Na Zhao Yanchun Tang Shaokun Wang Liping Cui Xuehui Sun Zhihua Wang Ying Liu
10.3389/fimmu.2022.981502
Front Immunol
2022 Sep 15;13:981502.
behçet’s syndrome case report intestinal diseases tofacitinib treatment
CC BY
https://pubmed.ncbi.nlm.nih.gov/36189238/
Behcet Syndrome / drug therapy Janus Kinase Inhibitors / therapeutic use Piperidines / therapeutic use Pyrimidines / therapeutic use
Behcet Syndrome / drug therapy Janus Kinase Inhibitors / therapeutic use Piperidines / therapeutic use Pyrimidines / therapeutic use Case Reports Review Antibodies, Monoclonal / therapeutic use Biological Factors / therapeutic use COVID-19 / epidemiology Humans Immunosuppressive Agents / therapeutic use Intestines / pathology Janus Kinases Prospective Studies Tumor Necrosis Factor Inhibitors Ulcer / drug therapy Antibodies, Monoclonal Biological Factors Immunosuppressive Agents Janus Kinase Inhibitors Piperidines Pyrimidines Tumor Necrosis Factor Inhibitors tofacitinib Janus Kinases
PMC9520193
36189238
Case report: Refractory intestinal Behçet's syndrome successfully treated with tofacitinib: A report of four cases
2022